Insulet

+$35.79 (+18.37%) Today
-$0.59 (-0.26%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Insulet and other ETFs, options, and stocks.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.

CEO
Shacey Petrovic
Employees
1,900
Headquarters
Acton, Massachusetts
Founded
2000

PODD Key Statistics

Market cap
15.90B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.07M
High today
$230.59
Low today
$211.20
Open price
$220.00
Volume
2.43M
52 Week high
$324.81
52 Week low
$193.70

PODD News

MarketWatch23h

Insulet Gets FDA OK for Omnipod 5 Automated Insulin-Delivery System

By Colin Kellaher Insulet Corp. on Friday said it received U.S. Food and Drug Administration approval for its Omnipod 5 automated insulin-delivery system for i
Simply Wall StJan 25

Insulet Has A Somewhat Strained Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonym

PODD Earnings

-$0.26
-$0.09
$0.07
$0.24
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Available Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure